Cancer Screening Guidelines

Lung Cancer Screening

Lung cancer is the leading cause of cancer death in the U.S. In 2015, it was estimated that 221,200 new cases of lung cancer (115,610 in men and 105,590 in women) will be diagnosed and 158,040 deaths from lung cancer (86,380 in men and 71,660 among women) will occur. However, there are more options for successful treatment when lung cancer is diagnosed in the early stages before the disease has escaped the lung.

Low Dose CT Screening for lung cancer was developed in response to evidence-based recommendations which found that screening with annual low-dose CT scans reduced the risk of dying from lung cancer by 20 percent compared to patients who were screened with chest X-rays. Lourdes has implemented the guidelines and criteria developed by the National Comprehensive Cancer Network (NCCN) in response to this research.

Why Get Screened?

The goal of screening is to detect lung cancer at a time when it is not causing symptoms and when treatment can be most successful. Screening should increase survival and quality of life. An important, recent study referred to as the National Lung Screening Trial (NLST) has demonstrated that screening under the appropriate conditions and in the right individuals can reduce death from lung cancer by 20%.

Who Can Benefit from a Lung Screening?

It is clear that only people considered at high risk will benefit. Risk is defined by age (usually between the ages of 55 and 77) and pack years of smoking. Pack years is calculated by multiplying the number of packs of cigarettes smoked per day by the number of years the person has smoked. Additional factors such as family or personal history of cancer or lung disease and occupational exposure can play a role and should be discussed with your doctor or a member of our lung team. We will only screen those individuals that are considered high risk.

CT Screening vs Chest X-Ray

When comparing low dose CT scans to standard chest X-rays when screening for lung cancer, researchers found significant advantages for the patient:

  1. Non-calcified nodules were three times more likely to show up.
  2. Cancerous tumors were four times more likely to be detected.
  3. Stage I cancers were six times more likely to be detected.

How Does the Screening Work?

CT Lung Screenings use an X-ray generating device that rotates around your body and a very powerful computer to create crosssectional images of the inside of your lungs. From these images, physicians can see small tumors, which may be more treatable by surgery or other procedures. The scan helps find cancerous nodules early, often before there is spread beyond the lung. It is important to understand that not all findings on the CT Lung Screening are cancerous and may not require treatment. Incidental findings will be managed or observed based on the discretion of the pulmonologist or primary care provider as appropriate.

We’re With You Every Step of the Way

Every person who is screened will meet with our Nurse Navigator who will make sure that all of your questions are answered and will also facilitate any follow up studies that are required. The Nurse Navigator will communicate with your referring physician and our lung team to ensure your comprehensive care. He or she will essentially guide you through the entire process.

To determine if you are a candidate for CT Lung Screening, contact our Nurse Navigator at 607-798-LUNG (5864).

LOURDES Hospital | 169 Riverside Drive • Binghamton, NY 13905 | Phone: 607-798-5111 / Directory | Email: